Stock Fundamentals

Company Information

Company Name
Kezar Life Sciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US49372L2097
CIK: 0001645666
CUSIP: 49372L100
Currency: USD
Full Time Employees: 9
Phone: 650 822 5600
Fiscal Year End: December
IPO Date: Jun 21, 2018
Description:

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Address:

4000 Shoreline Court, South San Francisco, CA, United States, 94080

Directors & Officers

Name Title Year Born
Dr. Christopher J. Kirk Ph.D. Co-Founder, CEO & Director 1972
Mr. John Franklin Fowler Co-Founder & Director 1972
Mr. Mark Schiller Chief Operations Officer 1980
Dr. Jack Taunton Ph.D. Co-Founder NA
Ms. Pichi Chiang Senior Vice President & Controller 1962

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jul 02, 2025 Mark C Schiller N/A Sale 561.00 $4.28 $2.40K
Jul 02, 2025 Pichi Luo Chiang N/A Sale 264.00 $4.28 $1.13K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BML Capital Management LLC 720.79K Mar 31, 2026 9.76% $3.43 0.00%
Suvretta Capital Management, LLC 716.76K Mar 31, 2026 9.70% $0.14 0.00%
TANG CAPITAL MANAGEMENT LLC 664.31K Mar 31, 2026 8.99% $0.25 0.00%
Vanguard Group Inc 341.40K Dec 31, 2025 4.62% $0.00 27.31%
Vanguard Capital Management, LLC 290.53K Mar 31, 2026 3.93% $0.00 0.00%
Affinity Asset Advisors, LLC 229.08K Mar 31, 2026 3.10% $0.09 0.00%
Renaissance Technologies Corp 188.43K Mar 31, 2026 2.55% $0.00 43.52%
Acadian Asset Management LLC 151.63K Mar 31, 2026 2.05% $0.00 0.00%
Millennium Management LLC 142.05K Mar 31, 2026 1.92% $0.00 0.00%
Peapod Lane Capital LLC 126.69K Mar 31, 2026 1.71% $0.76 -0.01%
Ikarian Capital, LLC 102.21K Mar 31, 2026 1.38% $0.06 0.00%
BlackRock Inc 100.06K Mar 31, 2026 1.35% $0.00 1.40%
ADAR1 Capital Management LLC 81.93K Mar 31, 2026 1.11% $0.04 -30.23%
Aldebaran Capital LLC 80.34K Mar 31, 2026 1.09% $0.46 -0.37%
Geode Capital Management, LLC 60.99K Mar 31, 2026 0.83% $0.00 -10.53%
Citadel Advisors Llc 59.40K Mar 31, 2026 0.80% $0.00 0.00%
TORNO CAPITAL LLC 48.48K Mar 31, 2026 0.66% $0.05 142.40%
Vanguard Fiduciary Trust Co 41.20K Mar 31, 2026 0.56% $0.00 0.00%
Dimensional Fund Advisors, Inc. 30.33K Mar 31, 2026 0.41% $0.00 14.28%
RBF LLC 28.14K Mar 31, 2026 0.38% $0.01 -50.00%

Shares Statistics

Shares Outstanding: 7.39M
Shares Float: 5.16M
% Insiders: 1,578.20%
% Institutions: 6,125.60%
Short % Float: 2.10%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 223.23K 3.02% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 67.30K 0.91% ▲ 0.00% Apr 30, 2026
3 Stork Fund Dynamic MultiStrategies O EUR 45.91K 0.62% ▲ 0.00% Mar 31, 2026
4 Fidelity Extended Market Index 14.94K 0.20% ▼ 44.71% Apr 30, 2026
5 Extended Equity Market Fund B 12.18K 0.16% ▲ 0.00% Dec 31, 2025
6 Blackrock Extended Mkt Fund CF 12.18K 0.16% ▲ 0.00% Apr 30, 2026
7 Extended Equity Market Fund E 12.18K 0.16% ▲ 0.00% Dec 31, 2025
8 Fidelity Total Market Index 10.68K 0.14% ▲ 0.00% Apr 30, 2026
9 BlackRock Extended Equity Market Fund K 10.37K 0.14% ▼ 0.73% Mar 31, 2026
10 Fidelity Global Micro-Cap F 10.00K 0.14% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $-15.62M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $53.86M
EBITDA: $-51.37M
Book Value: $9.56
Earnings/Share: $-6.17
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -29.52%
ROE (TTM): -59.93%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 11.52x 0.03x 0.09x -38.15x -0.05x
2024-12-31 6.76x 0.12x 0.19x -56.88x -0.17x
2023-12-31 11.66x 0.07x 0.15x -71.89x -0.13x
2022-12-31 25.98x 0.05x 0.10x -60.05x -0.18x
2021-12-31 25.77x 0.05x 0.10x -343.77x -0.20x
2020-12-31 22.48x 0.01x 0.07x -35.55x -0.03x
2019-12-31 13.52x 0.01x 0.13x N/A -0.02x
2018-12-31 32.91x 0.00x 0.05x N/A 0.00x
2017-12-31 35.26x 0.00x 1.47x N/A 0.00x
2016-12-31 16.11x 0.00x 2.53x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KZR.US!